Oriental Carbon and Chemicals (OCCL) Q4 15/16 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 15/16 earnings summary
2 Nov, 2026Executive summary
FY16 standalone PAT rose to Rs 5,298.73 lakh from Rs 5,131.60 lakh; net sales fell to Rs 27,471.72 lakh as lower input costs and weak global demand reduced realizations and export offtake.
Stronger margins and cost controls supported EBITDA of Rs 8,676.12 lakh, up from Rs 8,414.21 lakh; domestic demand for Insoluble Sulphur grew at a double-digit rate.
Financial highlights
Standalone total revenue was Rs 28,040.36 lakh vs Rs 29,543.48 lakh; PBT rose to Rs 6,476.32 lakh from Rs 6,296.21 lakh and PAT to Rs 5,298.73 lakh from Rs 5,131.60 lakh.
Standalone net revenue from operations was Rs 27,471.72 lakh vs Rs 28,257.35 lakh; EBITDA was Rs 8,676.12 lakh vs Rs 8,414.21 lakh.
Consolidated net revenue from operations was Rs 33,812.69 lakh vs Rs 34,666.62 lakh; profit attributable to the holding entity increased to Rs 4,952.18 lakh from Rs 4,829.08 lakh.
Interim dividend of Rs 3/share and proposed final dividend of Rs 5.50/share; total dividend was 85% of face value, including proposed final dividend.
Outlook and guidance
Insoluble Sulphur demand growth forecast at 2–3% internationally and double digits domestically; another outlook passage projects global growth of 3–4%, with lower growth expected in China.
Phase 1 of the Mundra Insoluble Sulphur expansion was scheduled for commissioning in April 2017; additional volumes were targeted for American and Chinese markets.
Sulphuric Acid demand was expected to improve with anticipated good monsoon conditions and fertilizer production.
Latest events from Oriental Carbon and Chemicals
- Profitable growth and a ₹216 crore expansion plan advance the next capacity phase.OCCL
Q4 18/19 - COVID-19 hit FY20 results; FY21 outlook signaled lower sales and delayed expansion.OCCL
Q4 19/20 - Higher FY18 profit and expanding Insoluble Sulphur capacity underpin the growth outlook.OCCL
Q4 17/18 - Mundra expansion and Insoluble Sulphur growth drive the FY2016-17 outlook.OCCL
Q4 16/17 - FY15 profit advanced as Insoluble Sulphur demand and capacity utilization strengthened.OCCL
Q4 14/15 - FY14 growth was led by Insoluble Sulphur, with expansion prospects shadowed by SEZ uncertainty.OCCL
Q4 13/14 - Sales rose, but lower tyre demand and higher costs cut earnings as Mundra Phase II ramped up.OCCL
Q4 12/13 - FY11 profit rose as capacity expansion targeted strong Insoluble Sulphur demand.OCCL
Q4 10/11 - Revenue grew 37%, while Mundra expansion lifted Insoluble Sulphur capacity amid higher costs and market risks.OCCL
Q4 11/12